NCT05556564

The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 100 (actual)
• Sponsor: PeriPharm · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This is a cross-sectional, real-world observational, community pharmacy-based study in which adults treated with a triptan for their migraine will self-report productivity and activity impairment using a web-based portal or paper-based questionnaire.

Detailed description

The primary objective of this study is to estimate the productivity and activity impairment associated with migraine in adults treated with a triptan. Participant identification will be made using pharmacies member of the PROxy Network. Eligible participants will be identified using the prescription of any formulation of triptans either when filling or refilling a prescription of a triptan or in the pharmacy electronic database (patients with a renewal in the last 3 months). The PROxy Network is a research network bringing together community pharmacies across Quebec to facilitate the generation of real-world evidence. This network is designed to better understand a disease or a treatment using patient-reported outcomes (PROs). The PROxy Network is an initiative of PeriPharm Inc., a company specializing in pharmacoeconomics and outcomes research.

Conditions

• Migraine

Interventions

Type	Name	Description
DRUG	observational study	No intervention, observational study

Timeline

• Start date: 2022-10-31
• Primary completion: 2023-03-06
• Completion: 2023-03-06
• First posted: 2022-09-27
• Last updated: 2023-04-21

Locations

1 site across 1 country: Canada